These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 18524979)

  • 1. MF63 [2-(6-chloro-1H-phenanthro[9,10-d]imidazol-2-yl)-isophthalonitrile], a selective microsomal prostaglandin E synthase-1 inhibitor, relieves pyresis and pain in preclinical models of inflammation.
    Xu D; Rowland SE; Clark P; Giroux A; Côté B; Guiral S; Salem M; Ducharme Y; Friesen RW; Méthot N; Mancini J; Audoly L; Riendeau D
    J Pharmacol Exp Ther; 2008 Sep; 326(3):754-63. PubMed ID: 18524979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual, constrictor-to-dilator, response of the mouse ductus arteriosus to the microsomal prostaglandin E synthase-1 inhibitor, 2-(6-chloro-1H-phenanthro[9,10d]imidazole- 2-yl)isophthalonitrile.
    Baragatti B; Scebba F; Sodini D; Pagni E; Ciofini E; Xu D; Coceani F
    Neonatology; 2011; 100(2):139-46. PubMed ID: 21372596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and Characterization of Novel Microsomal Prostaglandin E Synthase-1 Inhibitors for Analgesia.
    Chandrasekhar S; Harvey AK; Yu XP; Chambers MG; Oskins JL; Lin C; Seng TW; Thibodeaux SJ; Norman BH; Hughes NE; Schiffler MA; Fisher MJ
    J Pharmacol Exp Ther; 2016 Mar; 356(3):635-44. PubMed ID: 26740668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinction of microsomal prostaglandin E synthase-1 (mPGES-1) inhibition from cyclooxygenase-2 inhibition in cells using a novel, selective mPGES-1 inhibitor.
    Mbalaviele G; Pauley AM; Shaffer AF; Zweifel BS; Mathialagan S; Mnich SJ; Nemirovskiy OV; Carter J; Gierse JK; Wang JL; Vazquez ML; Moore WM; Masferrer JL
    Biochem Pharmacol; 2010 May; 79(10):1445-54. PubMed ID: 20067770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MF498 [N-{[4-(5,9-Diethoxy-6-oxo-6,8-dihydro-7H-pyrrolo[3,4-g]quinolin-7-yl)-3-methylbenzyl]sulfonyl}-2-(2-methoxyphenyl)acetamide], a selective E prostanoid receptor 4 antagonist, relieves joint inflammation and pain in rodent models of rheumatoid and osteoarthritis.
    Clark P; Rowland SE; Denis D; Mathieu MC; Stocco R; Poirier H; Burch J; Han Y; Audoly L; Therien AG; Xu D
    J Pharmacol Exp Ther; 2008 May; 325(2):425-34. PubMed ID: 18287210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The molecular pharmacology and in vivo activity of 2-(4-chloro-6-(2,3-dimethylphenylamino)pyrimidin-2-ylthio)octanoic acid (YS121), a dual inhibitor of microsomal prostaglandin E2 synthase-1 and 5-lipoxygenase.
    Koeberle A; Rossi A; Zettl H; Pergola C; Dehm F; Bauer J; Greiner C; Reckel S; Hoernig C; Northoff H; Bernhard F; Dötsch V; Sautebin L; Schubert-Zsilavecz M; Werz O
    J Pharmacol Exp Ther; 2010 Mar; 332(3):840-8. PubMed ID: 19934399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substituted phenanthrene imidazoles as potent, selective, and orally active mPGES-1 inhibitors.
    Côté B; Boulet L; Brideau C; Claveau D; Ethier D; Frenette R; Gagnon M; Giroux A; Guay J; Guiral S; Mancini J; Martins E; Massé F; Méthot N; Riendeau D; Rubin J; Xu D; Yu H; Ducharme Y; Friesen RW
    Bioorg Med Chem Lett; 2007 Dec; 17(24):6816-20. PubMed ID: 18029174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of AF3442 [N-(9-ethyl-9H-carbazol-3-yl)-2-(trifluoromethyl)benzamide], a novel inhibitor of human microsomal prostaglandin E synthase-1, on prostanoid biosynthesis in human monocytes in vitro.
    Bruno A; Di Francesco L; Coletta I; Mangano G; Alisi MA; Polenzani L; Milanese C; Anzellotti P; Ricciotti E; Dovizio M; Di Francesco A; Tacconelli S; Capone ML; Patrignani P
    Biochem Pharmacol; 2010 Apr; 79(7):974-81. PubMed ID: 19925781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microsomal prostaglandin E synthase-1 is a major terminal synthase that is selectively up-regulated during cyclooxygenase-2-dependent prostaglandin E2 production in the rat adjuvant-induced arthritis model.
    Claveau D; Sirinyan M; Guay J; Gordon R; Chan CC; Bureau Y; Riendeau D; Mancini JA
    J Immunol; 2003 May; 170(9):4738-44. PubMed ID: 12707354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of microsomal prostaglandin E synthase 1 inhibitors.
    Korotkova M; Jakobsson PJ
    Basic Clin Pharmacol Toxicol; 2014 Jan; 114(1):64-9. PubMed ID: 24138533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonacidic inhibitors of human microsomal prostaglandin synthase 1 (mPGES 1) identified by a multistep virtual screening protocol.
    Rörsch F; Wobst I; Zettl H; Schubert-Zsilavecz M; Grösch S; Geisslinger G; Schneider G; Proschak E
    J Med Chem; 2010 Jan; 53(2):911-5. PubMed ID: 20025212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microsomal prostaglandin E2 synthase-1 (mPGES-1): a novel anti-inflammatory therapeutic target.
    Friesen RW; Mancini JA
    J Med Chem; 2008 Jul; 51(14):4059-67. PubMed ID: 18459759
    [No Abstract]   [Full Text] [Related]  

  • 13. Synthesis and pharmacological evaluation of a selected library of new potential anti-inflammatory agents bearing the gamma-hydroxybutenolide scaffold: a new class of inhibitors of prostanoid production through the selective modulation of microsomal prostaglandin E synthase-1 expression.
    Guerrero MD; Aquino M; Bruno I; Terencio MC; Paya M; Riccio R; Gomez-Paloma L
    J Med Chem; 2007 May; 50(9):2176-84. PubMed ID: 17407277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of microsomal prostaglandin E-synthase-1 (mPGES-1) selectively suppresses PGE
    Martin EM; Jones SL
    Vet Immunol Immunopathol; 2017 Oct; 192():33-40. PubMed ID: 29042013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biarylimidazoles as inhibitors of microsomal prostaglandin E2 synthase-1.
    Wu TY; Juteau H; Ducharme Y; Friesen RW; Guiral S; Dufresne L; Poirier H; Salem M; Riendeau D; Mancini J; Brideau C
    Bioorg Med Chem Lett; 2010 Dec; 20(23):6978-82. PubMed ID: 20965723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitors of the microsomal prostaglandin E(2) synthase-1 as alternative to non steroidal anti-inflammatory drugs (NSAIDs)--a critical review.
    Koeberle A; Werz O
    Curr Med Chem; 2009; 16(32):4274-96. PubMed ID: 19754418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel selective prostaglandin E2 synthesis inhibitor relieves pyrexia and arthritis in Guinea pigs inflammatory models.
    Sugita R; Kubota K; Sugimoto K; Tachida Y; Shibayama T; Kiho T; Kawakami K; Shimada K
    J Pharmacol Sci; 2016 Feb; 130(2):128-35. PubMed ID: 26906248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of 2-((2-chloro-6-fluorophenyl)amino)-N-(3-fluoro-5-(trifluoromethyl)phenyl)-1-methyl-7,8-dihydro-1H-[1,4]dioxino[2',3':3,4]benzo[1,2-d]imidazole-5-carboxamide as potent, selective and efficacious microsomal prostaglandin E
    Muthukaman N; Deshmukh S; Sarode N; Tondlekar S; Tambe M; Pisal D; Shaikh M; Kattige VG; Honnegowda S; Karande V; Kulkarni A; Jadhav SB; Mahat MYA; Gudi GS; Khairatkar-Joshi N; Gharat LA
    Bioorg Med Chem Lett; 2016 Dec; 26(24):5977-5984. PubMed ID: 27865703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myrtucommulone, a natural acylphloroglucinol, inhibits microsomal prostaglandin E(2) synthase-1.
    Koeberle A; Pollastro F; Northoff H; Werz O
    Br J Pharmacol; 2009 Mar; 156(6):952-61. PubMed ID: 19298395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Licofelone suppresses prostaglandin E2 formation by interference with the inducible microsomal prostaglandin E2 synthase-1.
    Koeberle A; Siemoneit U; Bühring U; Northoff H; Laufer S; Albrecht W; Werz O
    J Pharmacol Exp Ther; 2008 Sep; 326(3):975-82. PubMed ID: 18550688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.